Research and Development

Showing 15 posts of 9594 posts found.

covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

August 5, 2020 Research and Development COVID-19, Weekly round up, coronavirus

The coronavirus news this week is dominated by vaccine development, as the UK Government sealed another deal to procure an …
coca-cola_bottles_for_thai_market_1

Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis

August 5, 2020 Research and Development, Sales and Marketing Coca-Cola, Coke

Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …
chrissy

Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
enoch_kariuki

VelosBio reveals new Chief Financial Officer

August 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment

Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
kymriah

Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma

August 4, 2020 Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy

Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …
1

CAR T cell therapy is revolutionising cancer treatment, but at what cost?

August 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature

CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
shutterstock_138095450

US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate

July 31, 2020 Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine

The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10

Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …
heart-2372134_640

Lilly and Boehringer’s Jardiance reduces hospitalisation and CV death risk from heart failure at Phase 3

July 30, 2020 Research and Development Boehringer, Eli Lilly, jardiance, pharma

Boehringer Ingelheim and Eli Lilly have announced strong Phase 3 news on their sodium-glucose co-transporter-2 (SGLT2) inhibitor Jardiance (empagliflozin) in …

Sanofi’s nirsevimab nails study goals for prevention of respiratory syncytial virus in infants

July 30, 2020 Research and Development Sanofi, nirsevimab, pharma

Sanofi’s nirsevimab met its goals in a Phase 2b study, the company has revealed, investigating its efficacy in the prevention …
shutter

UCB syncs up with Roche and Genentech in Alzheimer’s drug deal worth a potential $2bn+

July 30, 2020 Research and Development, Sales and Marketing Genentech, Roche, UCB, partnership

UCB Pharma is set to partner up with Roche and Genentech in a development and commercialisation deal focused on its …
vaccination-1215279_960_720

BioNTech’s melanoma vaccine shows promise in early interim analysis

July 30, 2020 Research and Development BioNTech, Cancer, pharma

While the company has more recently drawn headlines for its COVID-19 efforts, BioNTech has unveiled promising interim Phase 1 data …

Takeda poised to cut sales jobs in Japan as restructuring continues

July 29, 2020 Medical Communications, Research and Development, Sales and Marketing Japan, Takeda, job cuts

Japan’s biggest drug firm Takeda is said to be mulling plans to cut back its sales operations with a new …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

July 29, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

The once-touted COVID cure hydroxychloroquine continues its downward spiral of credibility as new data is published on its lack of …
novartis_outside_1

Novartis’ Piqray combo becomes first Europe-approved therapy for PIK3CA-mutated advanced breast cancer

July 29, 2020 Research and Development, Sales and Marketing Europe, Novartis, Piqray, breast cancer, pharma

The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …
The Gateway to Local Adoption Series

Latest content